Diabetes

Tirzepatide noninferior, superior to semaglutide for T2DM

(HealthDay)—The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, tirzepatide, is noninferior and superior to semaglutide for reducing glycated hemoglobin levels among patients ...

Diabetes

Midway waist circumference better than iliac crest measure

(HealthDay)—Waist circumference measured midway (WC-mid) between the lowest ribs and the iliac crest better defines risks associated with central obesity than does waist circumference measured at the iliac crest (WC-IC), ...

Diabetes

Bias may play a role in underdiagnoses of prediabetes

The accurate diagnosis of prediabetes in the primary care setting might depend on a patient's age, BMI, gender, race and certain comorbidities, according to research being presented at ENDO 2022, the Endocrine Society's annual ...

Diabetes

HbA1c targets should be personalized in type 2 diabetes

(HealthDay)—For non-pregnant adults with type 2 diabetes, hemoglobin A1c (HbA1c) targets should be personalized, according to a Clinical Guidelines Synopsis published in the June 19 issue of the Journal of the American ...

Diabetes

Daily vibration may combat prediabetes in youth

Daily sessions of whole-body vibration may combat prediabetes in adolescents, dramatically reducing inflammation, average blood glucose levels and symptoms such as frequent urination, researchers report.

page 4 from 10